IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $298,000 | +20.2% | 9,050 | 0.0% | 0.05% | +10.2% |
| Q2 2020 | $248,000 | -41.1% | 9,050 | -35.6% | 0.05% | -51.0% |
| Q1 2020 | $421,000 | +1.7% | 14,050 | -6.1% | 0.10% | +23.5% |
| Q4 2019 | $414,000 | +9.8% | 14,970 | -27.8% | 0.08% | +5.2% |
| Q3 2019 | $377,000 | -25.8% | 20,725 | 0.0% | 0.08% | -25.2% |
| Q2 2019 | $508,000 | +157.9% | 20,725 | 0.0% | 0.10% | +151.2% |
| Q1 2019 | $197,000 | +7.7% | 20,725 | 0.0% | 0.04% | -2.4% |
| Q4 2018 | $183,000 | -21.5% | 20,725 | 0.0% | 0.04% | -10.6% |
| Q3 2018 | $233,000 | -12.1% | 20,725 | 0.0% | 0.05% | -11.3% |
| Q2 2018 | $265,000 | -24.3% | 20,725 | 0.0% | 0.05% | -26.4% |
| Q1 2018 | $350,000 | +212.5% | 20,725 | +47.5% | 0.07% | +213.0% |
| Q4 2017 | $112,000 | +2.8% | 14,050 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $109,000 | – | 14,050 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |